Fingerprint
Dive into the research topics of 'Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro
Yoon Woo Koh, Manisha H. Shah, Kitty Agarwal, Samantha K. McCarty, Bon Seok Koo, Victoria J. Brendel, Chaojie Wang, Kyle Porter, David Jarjoura, Motoyasu Saji, Matthew D. Ringel
Research output: Contribution to journal › Article › peer-review
28
Citations
(Scopus)